Markets:

Overview

News

Currencies

International

Treasuries

Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)

1.280 +0.050 (+4.07%)

Official Closing Price Updated: 4:10 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lineage Cell Therapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering

February 06, 2024

From Lineage Cell Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 01, 2024

Via Benzinga

Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying ↗

January 03, 2024

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Lineage Cell Therapeutics: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Earnings Preview: Lineage Cell Therapeutics ↗

November 08, 2023

Via Benzinga

Lineage Cell Therapeutics Earnings Preview ↗

August 09, 2023

Via Benzinga

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

January 16, 2024

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 29, 2023

Via Benzinga

Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury

December 18, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

3 Penny Stocks to Buy for the Next Bull Run ↗

November 11, 2023

While penny stocks to buy represent a terribly risky venture, it’s possible that maybe one of these ideas could skyrocket.

Via InvestorPlace

Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 09, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023

November 01, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting

October 24, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks ↗

October 17, 2023

Here are the best longevity stocks to consider. Each stock listed comes with their unique reasons to buy them.

Via InvestorPlace

Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023

September 19, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells

October 11, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics ↗

September 06, 2023

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and...

Via Benzinga

RG6501 (OpRegen®) Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

October 05, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage to Present at Baird 2023 Global Healthcare Conference and H.C. Wainwright & Co. 25th Annual Global Investment Conference

August 29, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

RG6501 (OpRegen®) Phase 1/2a Additional Results to Be Featured at 23rd EURETINA Congress

September 13, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗

August 16, 2023

Gainers

Via Benzinga

Lineage to Present at 2023 International Spinal Research Trust Network Meeting

September 11, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

August 10, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics

September 06, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Update on August 10, 2023

August 03, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Lineage Cell Therapeutics' Lung Cancer Vaccine: Initial Data Reveals Modest, Durable Immune Response ↗

July 24, 2023

Lineage Cell Therapeutics Inc (NYSE: LCTX) and Cancer Research UK revealed primary and secondary endpoint results from the recently completed clinical study of VAC2 in advanced non-small

Via Benzinga

Lineage Cell Therapeutics and Cancer Research UK Report Topline Phase 1 Study Results With VAC2 for the Treatment of Advanced Non-small Cell Lung Cancer

July 24, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index

May 22, 2023

From Lineage Cell Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.